10th Dec 2008 17:48
BTG plc: Director's Share Dealing
London, UK, 10 December 2008: BTG plc (LSE: BGC) ("BTG" or "the Company"), the specialty pharmaceutical company, announces that it was informed today that Rolf Soderstrom, who joined the BTG Board of Directors as Chief Financial Officer on 4 December 2008, yesterday sold 133,339 ordinary BTG shares of 10 pence each at a price of 154.3685 pence per share.
These shares were sold primarily to meet Mr Soderstrom's tax and National Insurance liabilities arising from the vesting of his share awards in Protherics plc ("Protherics"), which converted into BTG shares on 4 December 2008 upon the Scheme of Arrangement by which BTG acquired Protherics becoming effective.
Mr Soderstrom was previously Finance Director of Protherics. There are no further details to be disclosed in relation to paragraph 9.6.13R of the Financial Services Authority Listing Rules.
Following this transaction, Mr Soderstrom is the beneficial owner of 79,857 Ordinary Shares in BTG, representing 0.03% of the Company's current issued share capital.
Mr Soderstrom has informed the Company that he does not anticipate selling any further shares in the foreseeable future.
For further information contact:Andy Burrows, Director of Investor Relations +44(0)20 7575 1741
Related Shares:
BTG